These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 7331837)

  • 1. [Liberation of active substances from suppository bases. II. In vivo studies of phenobarbital suppositories].
    Grzesiczak A; Ludwicki H; Ostrowska E
    Acta Pol Pharm; 1981; 38(4):493-7. PubMed ID: 7331837
    [No Abstract]   [Full Text] [Related]  

  • 2. Biopharmaceutical investigation of rectal suppositories. Part 2(1): Pharmaceutical and biological availability of phenobarbital and phenobarbital-sodium.
    Minkov E; Lambov N; Kirchev D; Bantutova I; Tencheva J
    Pharmazie; 1985 Apr; 40(4):257-9. PubMed ID: 3839310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [On the action of various factors on the liberation from suppositories (author's transl)].
    Bornschein M; Grohmann A; Voigt R
    Pharmazie; 1980 Dec; 35(12):772-6. PubMed ID: 7208579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Dissolution of phenobarbital from anal suppositories (investigations in vitro) (author's transl)].
    Nerlo H; Kosior A
    Ann Univ Mariae Curie Sklodowska Med; 1978; 33():255-9. PubMed ID: 757936
    [No Abstract]   [Full Text] [Related]  

  • 5. Biopharmaceutical investigations of rectal suppositories. Part 1: Pharmaceutical and biological availability of theophylline.
    Minkov E; Lambov N; Kirchev D; Bantutova I; Tencheva J
    Pharmazie; 1984 Apr; 39(4):242-3. PubMed ID: 6547533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Availability of phenobarbital from suppository form (author's transl)].
    Puech A; Lasserre Y; Jacob M; Duru C
    J Pharm Belg; 1981; 36(5):332-6. PubMed ID: 7310627
    [No Abstract]   [Full Text] [Related]  

  • 7. [Kinetics of liberation from suppository bases of phenobarbital acid and sodium and a semi-synthetic glyceride (Witepsol H 15). II. Suppositories after storage].
    Lasserre Y; Peneva MB; Jacob M; Puech A; Sabatier R
    Pharm Acta Helv; 1987; 62(10-11):287-91. PubMed ID: 3438314
    [No Abstract]   [Full Text] [Related]  

  • 8. Reciprocating dialysis tube method: periodic tapping improved in vitro release/dissolution testing of suppositories.
    Itoh S; Teraoka N; Matsuda T; Okamoto K; Takagi T; Oo C; Danny Kao H
    Eur J Pharm Biopharm; 2006 Nov; 64(3):393-8. PubMed ID: 16890412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biopharmaceutical investigation of rectal suppositories. Part 3: Influence of particle size on the bioavailability of drugs.
    Minkov E; Lambov N; Peneva B
    Pharmazie; 1986 Jan; 41(1):63-4. PubMed ID: 3960955
    [No Abstract]   [Full Text] [Related]  

  • 10. [Selection of bases for antibiotic-containing suppositories. III. Study of biological availability of antibiotics in some suppository bases].
    Zaremba A; Krówczyński L
    Acta Pol Pharm; 1975; 32(1):89-93. PubMed ID: 1114920
    [No Abstract]   [Full Text] [Related]  

  • 11. In-vitro evaluation and vaginal absorption of metronidazole suppositories in rabbits.
    Ozyazici M; Turgut EH; Taner MS; Köseoglu K; Ertan G
    J Drug Target; 2003 Apr; 11(3):177-85. PubMed ID: 14577974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The dynamics of the drug release from suppositories. Part 5: Liberation of chlorpromazine from suppository bases (author's transl)].
    Pasich J; Drobnicka B; Kasprzyk A
    Pharmazie; 1981; 36(1):20. PubMed ID: 7220580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioavailability of phenobarbital by rectal administration.
    Matsukura M; Higashi A; Ikeda T; Matsuda I
    Pediatr Pharmacol (New York); 1981; 1(3):259-65. PubMed ID: 7346746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on aminophenazone and phenobarbital release from suppositories prepared on different bases.
    Piasecka H; Zakrzewski Z
    Pol J Pharmacol Pharm; 1976; 28(2):199-203. PubMed ID: 934948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of drug solubility on in vitro availability rate from suppositories with polyethylene glycol excipients.
    Realdon N; Ragazzi E; Ragazzi E
    Pharmazie; 2001 Feb; 56(2):163-7. PubMed ID: 11234347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Availability of oxyphenbutazone from different suppository formulations.
    Ibrahim SA; Abd Elbary A; Elsorady H; Abd Elmonem H
    Pharmazie; 1980; 35(4):213-6. PubMed ID: 7403242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Biopharmaceutical evaluation of aminophylline suppositories. II. Biological availability of aminophylline (theophylline) from suppositories with normal and prolonged time of total deformation].
    Masiakowski J; Cieszyński T; Dyderski S; Perz A
    Acta Pol Pharm; 1984; 41(1):105-10. PubMed ID: 6496133
    [No Abstract]   [Full Text] [Related]  

  • 18. [Choice of bases for suppositories with antibiotics. II. Liberation of antibiotics in vitro from suppository bases].
    Zaremba A; Krówczyński L
    Acta Pol Pharm; 1974; 31(6):775-9. PubMed ID: 4447039
    [No Abstract]   [Full Text] [Related]  

  • 19. [Acetaminophen-containing suppositories in vitro and in vivo].
    Regdon G; Szikszay M; Gebri G; Regdon G
    Acta Pharm Hung; 1994 Mar; 64(2):45-9. PubMed ID: 8017207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced absorption of phenobarbital from suppositories containing phenobarbital povidone coprecipitate.
    Iwaoku R; Okamatsu Y; Kino S; Arimori K; Nakano M
    Chem Pharm Bull (Tokyo); 1984 Mar; 32(3):1091-5. PubMed ID: 6744481
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.